BNOAT ONCOLOGY, INC.

Basic Information

411 WOLF LEDGES PKWY STE 105
AKRON, OH, 44311-1051

Company Profile

n/a

Additional Details

Field Value
DUNS: 961695025
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. PURIFICATION, REFORMULATION AND PHARMACOKINETICS OF NITROSYLCO

    Amount: $200,000.00

    Oncology remains a major market of unmet need. BNOAT Oncology¿s long-term objective is New Drug Approval of its lead candidate nitrosylcobalamin, a tumor-specific, apoptosis-inducing, anti-canc ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government